a2 Milk made strong gains in Chinese infant formula market share in the first half on excellent marketing and execution, Credit Suisse declares. Brand awareness continues to improve in China. Upside risk is nonetheless difficult because the Chinese infant formula demand rate of decline appears to have quickened. The broker's modelling now suggests a further -10% decline in demand in 2023. Credit Suisse is concerned the China re-registration process could cause market disorder. Downgrade to Underperform from Neutral on valuation. Target falls to $5.10 from $5.30.
- Forums
- ASX - By Stock
- A2M
- Media Updates
Media Updates, page-12300
-
-
- There are more pages in this discussion • 2,419 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
NEWS
First paediatric clinical site activated – major recruitment milestone and key appointment announced
NEWS
Exceptional lithium assays uncovered at Falcon Lake – expanding mineralisation, big potential ahead
Add A2M (ASX) to my watchlist
(20min delay)
|
|||||
Last
$5.63 |
Change
-0.010(0.18%) |
Mkt cap ! $4.076B |
Open | High | Low | Value | Volume |
$5.62 | $5.67 | $5.56 | $7.763M | 1.381M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 39206 | $5.61 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$5.65 | 5630 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 39206 | 5.610 |
3 | 9975 | 5.600 |
1 | 5489 | 5.590 |
2 | 16523 | 5.580 |
1 | 1000 | 5.560 |
Price($) | Vol. | No. |
---|---|---|
5.650 | 5630 | 4 |
5.660 | 26018 | 2 |
5.670 | 1100 | 2 |
5.680 | 6983 | 3 |
5.690 | 6388 | 3 |
Last trade - 16.10pm 12/09/2024 (20 minute delay) ? |
Featured News
A2M (ASX) Chart |